Paul Eckburg
Directeur Technique/Scientifique/R&D chez AN2 THERAPEUTICS, INC.
Fortune : 110 544 $ au 30/06/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Eric Easom | M | 56 | 7 ans | |
| Marc Tessier-Lavigne | M | 64 |
Stanford University
| 9 ans |
| Joseph Zakrzewski | M | 60 | 7 ans | |
| Robin Readnour | M | 60 | 5 ans | |
| Melvin Spigelman | M | 75 | 2 ans | |
| Lucy Day | F | 65 | 5 ans | |
| Jaime José Serra Puche | M | 73 |
Stanford University
| - |
| Ali Ojjeh | M | 57 |
Stanford University
| - |
| Jeffrey H. Kleck | M | - |
Stanford University
| - |
| Morten Otto Sommer | M | 43 |
UTILITY therapeutics Ltd.
 UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | 6 ans |
| Arun Majumdar | M | 60 |
Stanford University
| 10 ans |
| Stephanie Wong | F | 50 | 3 ans | |
| Michael Genesereth | M | - |
Stanford University
| - |
| Kabeer Aziz | M | 34 | 5 ans | |
| Amy Zegart | M | 56 |
Stanford University
| - |
| Michael R. K. Alley | M | - | 7 ans | |
| Rasmus Toft-Kehler | M | - |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | 6 ans |
| Gilbert Marks | M | 66 | 4 ans | |
| Peter Aksel Villadsen | M | - |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | 6 ans |
| Tess Hau | F | - |
Stanford University
| 12 ans |
| Patricia Martin | F | 63 | 3 ans | |
| Josh Eizen | M | 46 | 2 ans | |
| Paul Koontz | M | 64 |
Stanford University
| - |
| Mark Stevens | M | 64 |
Stanford University
| - |
| John Morgridge | M | 91 |
Stanford University
| - |
| Yi Cui | M | - |
Stanford University
| - |
| Stephen R. Brown | M | - |
Stanford University
| - |
| Daphne Koller | M | - |
Stanford University
| - |
| Ashby Monk | M | - |
Stanford University
| - |
| Gordon Matheson | M | - |
Stanford University
| - |
| Carolyn Bertozzi | M | 57 |
Stanford University
| - |
| Rebeca Hwang | M | - |
Stanford University
| 20 ans |
| Rob Reich | M | - |
Stanford University
| - |
| Maria Grazia Roncarolo | M | 69 |
Stanford University
| 10 ans |
| Steve Krausz | M | 69 |
Stanford University
| 15 ans |
| Geoffrey West | M | 84 |
Stanford University
| 54 ans |
| Roeland Nusse | M | 74 |
Stanford University
| 34 ans |
| Brian Kobilka | M | - |
Stanford University
| - |
| Daniel Palanker | M | - |
Stanford University
| - |
| Francis Fukuyama | M | - |
Stanford University
| - |
| Ronald Johnson | M | 66 |
Stanford University
| - |
| Mark A. Horowitz | M | 66 |
Stanford University
| 40 ans |
| Mark A. Lemley | M | - |
Stanford University
| - |
| Siu-Weng Wong | M | 69 |
Stanford University
| 36 ans |
| Ronald Spogli | M | 75 |
Stanford University
| - |
| Mario L. Baeza | M | 72 |
Stanford University
| - |
| Steven Blank | M | 70 |
Stanford University
| - |
| Albert Dien | M | - |
Stanford University
| - |
| Peter D. O'Hanley | M | 73 |
Stanford University
| 39 ans |
| Judith Shizuru | M | 68 |
Stanford University
| - |
| Matthew Porteus | M | 59 |
Stanford University
| - |
| Condoleezza Rice | M | 69 |
Stanford University
| 15 ans |
| Jack P. Dvorkin | M | - |
Stanford University
| 35 ans |
| Jenny Dearborn | F | - |
Stanford University
| 2 ans |
| Charles Eesley | M | 44 |
Stanford University
| 15 ans |
| Chris Gerdes | M | - |
Stanford University
| - |
| Michael H. Armacost | M | 86 |
Stanford University
| 22 ans |
| Matthew Klein | M | 52 |
Stanford University
| - |
| Robert L. Joss | M | 82 |
Stanford University
| 25 ans |
| Aneel Bhusri | M | 58 |
Stanford University
| 5 ans |
| Fred M. Gibbons | M | 75 |
Stanford University
| 18 ans |
| Robert O. Ryan | M | - |
Stanford University
| - |
| Sebastian Thrun | M | 57 |
Stanford University
| - |
| Victoria Rogers | F | 63 |
Stanford University
| - |
| Elizabeth Weatherman | F | 64 |
Stanford University
| - |
| Joseph Hei | M | - |
Stanford University
| - |
| Peter Fitzgerald | M | 66 |
Stanford University
| - |
| Richard Douglas Rivers | M | - |
Stanford University
| 35 ans |
| Kyeongjae Cho | M | - |
Stanford University
| - |
| Mike E. Gertner | M | - |
Stanford University
| - |
| Thomas Charles Merigan | M | 90 |
Stanford University
| 36 ans |
| John Kembel | M | - |
Stanford University
| - |
| Frederick L. Allen | M | - |
Stanford University
| - |
| Benjamin van Roy | M | - |
Stanford University
| 26 ans |
| Ira D. Hall | M | 78 |
Stanford University
| - |
| Michael C. Bush | M | 66 |
Stanford University
| - |
| Eugene C. Butcher | M | - |
Stanford University
| - |
| Joseph Mandato | M | 80 |
Stanford University
| - |
| Armando Garza Sada | M | 67 |
Stanford University
| - |
| Bill McDonough | M | - |
Stanford University
| 20 ans |
| Thomas H. Lee | M | 64 |
Stanford University
| 30 ans |
| Dave Burke | M | - |
Stanford University
| 6 ans |
| Bernd Girod | M | - |
Stanford University
| 25 ans |
| Ge Wang | M | - |
Stanford University
| - |
| Jari Eerik Koistinaho | M | - |
Stanford University
| - |
| Dennis Sheehan | M | - |
Stanford University
| - |
| Tony Wyss-Coray | M | - |
Stanford University
| - |
| Daniel D. Gretler | M | - |
Stanford University
| 23 ans |
| Victoria P. Sant | F | - |
Stanford University
| - |
| J. David Powell | M | - |
Stanford University
| - |
| George Edwin SyCip | M | 67 |
Stanford University
| - |
| Thomas Quertermous | M | 71 |
Stanford University
| 27 ans |
| Laurence Jay Korn | M | 74 |
Stanford University
| - |
| Stephen D. Quake | M | 54 |
Stanford University
| 16 ans |
| Francis Siciliano | M | 52 |
Stanford University
| - |
| Mark D. Mordell | M | - |
Stanford University
| - |
| Sarvjit Singh Dhillon | M | 57 |
Stanford University
| - |
| Louis P. Eatman | M | - |
Stanford University
| - |
| Fouad A. Tobagi | M | - |
Stanford University
| - |
| John M. Cioffi | M | 66 |
Stanford University
| 38 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 97 | 97,00% |
| Royaume-Uni | 3 | 3,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Paul Eckburg
- Réseau Personnel
